Intelligent Bio Solutions Inc.
INBS · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.9% | 147.6% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 40.8% | 45.8% | 26% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -309.7% | -299.1% | -753.8% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -346.2% | -326.4% | -845.9% | – |
| EPS Diluted | -20 | -63.8 | -105.8 | -113.3 |
| % Growth | 68.7% | 39.7% | 6.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |